Cheap antidepressant slashes risk of severe COVID-19 by a third in breakthrough study

THE UK must wield every weapon it can against COVID-19 this winter, as new daily cases continue to spiral. A new treatment may be added to the protective arsenal. A cheap antidepressant has been shown to cut the risk of the unvaccinated Covid patient requiring hospitalisation by a third.